Method for identifying pharmaceutically active compound for treating state caused by changing expression of insulin receptor
DE10259004A1
11β-substituted steroids, as glucocorticoid receptor antagonists and their use
DE10251028A1
Use of progesterone or a progesterone receptor agonist to inhibit steroid synthesis
DE10221190A1
Module for culture of adherent cells has cell support, through which culture medium flows from inlet to outlet, additional pipe allowing extra modules to be fitted when connected to inlet
JP2003018996A
Test method for hormone action of material
DE10218106A1
Process for the production of crystals of active pharmaceutical ingredients, then obtainable crystals and their use in pharmaceutical formulations
DE10218110A1
Process for the preparation of crystals of pharmaceutical excipients, crystals available thereafter and their use in pharmaceutical formulations
DE10218109A1
Process for the production of crystals, then available crystals and their use in pharmaceutical formulations
DE10218107A1
Process for the production of crystals of steroids, crystals available thereafter and their use in pharmaceutical formulations
EP1350541A1
Use of dehydroepiandrosterone and an estradiol derivative for preparing a medicament for treating postmenopausal climacteric disorders
EP1350513A1
Soft gelatine capsule comprising an 17-alpha-estradiol compound and ascorbic acid
DE10211915A1
Identifying agents for treating conditions caused by altered expression of insulin receptors, specifically erectile dysfunction, by detecting splice variants of the receptor, also for diagnosis
EP1312365A1
Pteridinones for the treatment of erectile dysfunctions
DE10161325A1
Assessing hormonal effects of compounds, useful in testing drugs, from effect on interaction of nuclear receptor and co-modulator, also diagnosing diseases caused by improper co-modulation
US6855836B2
17-Methylene steroids, process for their production and pharmaceutical compositions that contain these compounds
DE10141984A1
New 17-methylene-4-azasteroids
DE10140113A1
Use of glucocorticoid receptor antagonists to prevent or treat disorders caused by reduced androgen production, especially male hypogonadism, male sexual dysfunction and infertility
DE10139494A1
Antitumor effective 2-alkoxyestradiol sulfamates
DE10135787A1
New nucleic acid for producing a recombinant polypeptide, for use as a probe, or for the treatment of steroidal hormone dependent illnesses
US6689768B2
Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy
